IGI Logo

Market Updates

The markets are expected to open marginally higher today as trends in GIFT NIFTY indicate a positive start for the broader index after NIFTY closed 365 points lower at 25,454 on Thursday.

ACME Solar

The company through subsidiary signed 25 year PPA with SECI for 190 MW wind solar hybrid project in Andhra Pradesh taking total PPA signed portfolio to 5,820 MW.

Avenue Supermarts

The company opens a new store in Gachibowli, Telangana, bringing its total store count to 449.

Delhivery

The company partnered with NVIDIA to build AI powered location intelligence and digital mapping solutions for India leveraging accelerated computing and proprietary shipment data.

IFGL Refractories

The company commenced a new plastic refractories line at its Vizag facility with 10,000 MT p.a. capacity involving ?2.1 crore capex funded largely via internal accruals.

Inox Green Energy Services

The company along with Inox Clean emerged as successful bidder under NCLT process to acquire Wind World India’s 600 MW IPP portfolio and 4.5 GW wind O&M business.

Mahindra & Mahindra

The company along with Embraer announced plans to establish C-390 Millennium MRO capability in India subject to selection in Indian Air Force MTA program.

Mahindra Holidays

The company launched a 57 key Club Mahindra Nadiya Parao Resort in Jim Corbett expanding presence in Uttarakhand and strengthening its leisure hospitality portfolio.

RailTel Corporation

The company received LoA for a railway signalling project from Dy CSTE P Cnb valued at ~?35.5 crore to be executed within 24 months.

SpiceJet

The company signed MoU to induct 10 aircraft as part of fleet ramp up to 60 aircraft with capacity targeted to exceed 220 crore ASK and over 300 daily flights by Winter 2026.

Texmaco Rail & Engineering

The company entered into a JV with RVNL for advanced rolling stock, lifecycle maintenance, asset management, and large-scale EPC and turnkey rail infrastructure projects in India and overseas, with a 49% stake.

Zydus Lifesciences

The company launched ANYRA its indigenously developed Aflibercept 2 mg biosimilar for retinal disorders and signed agreement with Regeneron and Bayer expanding its biosimilars portfolio.

Please refer disclaimer at http://www.aretesecurities.com/

SEBI Regn. No.: INM0000127